The Cooper Companies Inc (Cooper) is a medical device company primarily catering to fertility and vision care markets. It provides contact lenses to ophthalmologists, optometrists, opticians, optical chains, and distributors; and women’s healthcare products to hospitals, laboratories, and fertility clinics.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Cooper emphasizes addressing the ongoing issues and untapped areas in the eyecare and fertility markets. CooperVision focuses on the development of new contact lens designs, myopia management, and manufacturing technologies, along with improving formulations and existing products. It collaborates with both internal and external specialists in lens design, formulation science, polymer chemistry, engineering, clinical trials, microbiology, and biochemistry. CooperSurgical focuses on innovating, and advancing existing products and services including, instruments, devices, consumables, digital services, and manufacturing technologies. It collaborates with external specialists in mechanical, electrical, biomedical, and software engineering, as well as life sciences. In FY2023, Cooper spent US$137.4 million on its R&D, which was 3.82% of its revenue.